North Potomac, MD, United States of America

Ji He


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Ji He

Introduction

Ji He, based in North Potomac, Maryland, is making significant strides in the field of immunotherapy. He is recognized for his original contributions to personalized medicine, particularly through his innovative patent.

Latest Patents

Ji He holds a patent for "Methods and systems for determining personalized therapies." This groundbreaking method focuses on generating an immune score, which involves several critical assessments: determining the qualitative and/or quantitative evaluation of tumor infiltrating lymphocytes, assessing T-cell receptor signaling, evaluating mutation burden, and using a predictive algorithm to produce an immune score based on these assessments. This patent is a testament to his commitment to advancing cancer treatment through personalized approaches.

Career Highlights

Currently, Ji He is employed at Omniseq, Inc., where he leverages his expertise in immunology and data analysis. His innovative work in the company showcases his role in transforming the landscape of cancer therapies to tailor treatments to individual patients’ needs.

Collaborations

Alongside notable colleagues such as Carl Morrison and Sarabjot Pabla, Ji He contributes to a collaborative environment that fosters innovation and scientific progress. Together, they work on advancing the understanding and application of immunotherapy, driving forward the mission of providing personalized medicine.

Conclusion

Ji He’s contributions, particularly his patented method for determining personalized therapies, highlight his impact on the field of immunology. His work at Omniseq, Inc. and collaborations with esteemed colleagues position him as a prominent inventor committed to the future of personalized cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…